OptimizeRx Corporation OPRX
Set alert
9.41 USD 0.00 0.00%
At close
9.26 -0.15 -1.59%
Pre-market · Nov 3, 4:29 AM ET
9.30 Day range 9.64
4.54 52-week range 19.69
- YTD
- -23.25%
- 1 year
- -51.59%
- Open
- 9.48
- Prev close
- 9.41
- Mkt cap
- 177.25M
- Vol
- 148.28K
- Avg vol
- 181.06K
- EPS
- 0.24
- P/E
- 39.21
- Div yield
- 0.00%
More statistics
- Low
- 9.30
- High
- 9.64
- Forward P/E
- 9.86
- Beta
- 0.00
- Short ratio
- 2.70
- Inst. own
- 68.94%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 5.40
- 200-d avg
- 8.91
- 1y target
- 10.36
3M chart
Signals (12)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 19, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 12, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 25, 2026 | 1 month ago |
| SMA: Bullish | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 24, 2026 | 2 months ago |
| RSI: Overbought | Aug 13, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 5, 2026 | 3 months ago |
Analyst view
Consensus: buy
Buy
Price target (mean) 10.36 +10.1% upside
Now 9.41
- Target (low)
- 5.50
- Target (mean)
- 10.36
- Target (high)
- 17.00
Ratings (0m) 8 7 buy · 1 hold · 0 sell
- Strong buy3
- Buy4
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 7
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.25 | 0.20 – 0.28 | 0.26 | -3.9% | 29.70M | +4.7% | 8 |
| Next quarter | -0.03 | -0.05 – 0.03 | -0.11 | +72.7% | 21.26M | +8.0% | 5 |
| Current year | 0.28625 | 0.24 – 0.32 | 0.26 | +10.1% | 89.50M | +25.1% | 8 |
| Next year | 0.36 | 0.20 – 0.48 | 0.28625 | +25.8% | 100.26M | +12.0% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 20, 2024 | Stephens & Co. | Initiated | — | Equal-Weight |
| Nov 14, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 14, 2024 | Roth MKM | Reiterated | Buy | Buy |
| Nov 14, 2024 | Stifel | Maintained | Buy | Buy |
| Nov 14, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Nov 14, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Aug 16, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 12, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jun 24, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Jun 21, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| May 15, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| May 15, 2024 | Stifel | Maintained | Buy | Buy |
| Apr 16, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Apr 4, 2024 | JMP Securities | Initiated | — | Market Outperform |
| Apr 1, 2024 | Stifel | Maintained | Buy | Buy |
| Apr 1, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Jan 10, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Jan 3, 2024 | Barclays | Initiated | — | Equal-Weight |
| Aug 15, 2023 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 15, 2023 | Lake Street | Maintained | Buy | Buy |
| Aug 15, 2023 | Roth MKM | Maintained | Buy | Buy |
| Aug 15, 2023 | B. Riley Securities | Maintained | Buy | Buy |
| Aug 15, 2023 | Stifel | Maintained | Buy | Buy |
| Mar 9, 2023 | RBC Capital | Maintained | — | Outperform |
| Nov 1, 2022 | Stifel | Initiated | — | Buy |
| Oct 31, 2022 | Stifel | Initiated | — | Buy |
| Aug 10, 2022 | RBC Capital | Maintained | — | Outperform |
| Aug 10, 2022 | Piper Sandler | Maintained | — | Neutral |
| Aug 10, 2022 | SVB Leerink | Maintained | — | Outperform |
| Jul 20, 2022 | B. Riley Securities | Maintained | — | Buy |